Iván Sanz Muñoz-rekin lankidetzan egindako argitalpenak (43)

2024

  1. Analyzing Changes in Attitudes and Behaviors towards Seasonal Influenza Vaccination in Spain’s Adult Population over Three Seasons

    Vaccines, Vol. 12, Núm. 10

  2. Association of viral loads of influenza A (H3N2) with age and care setting on presentation—a prospective study during the 2022-2023 influenza season in Spain

    International Journal of Infectious Diseases, Vol. 143

  3. Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept (Front. Immunol., (2022), 13, (918887), 10.3389/fimmu.2022.918887)

    Frontiers in Immunology

  4. Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

    Eurosurveillance, Vol. 29, Núm. 6

  5. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

    Journal of Headache and Pain, Vol. 25, Núm. 1

  6. Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

    Scientific Reports, Vol. 14, Núm. 1

  7. Importancia de los Centros Nacionales de Gripe en la vigilancia de virus aviares de alta patogenicidad. El momento para One-Health es ahora

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 121-126

  8. Improved comprehension of influenza-related headaches: Perspectives and suggestions for incidence and prevalence of headache in influenza—Response

    European Journal of Neurology

  9. Incidence and prevalence of headache in influenza: A 2010–2021 surveillance-based study

    European Journal of Neurology, Vol. 31, Núm. 8

  10. MiRNome Profiling of Extracellular Vesicles in Patients with Severe COVID-19 and Identification of Predictors of Mortality

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. 901-911

  11. Microbiological and epidemiological features of respiratory syncytial virus

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 3, pp. 209-220

  12. Potential Effects on Elderly People From Nirsevimab Use in Infants

    Open Respiratory Archives, Vol. 6, Núm. 2

  13. RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Infectious Diseases and Therapy, Vol. 13, Núm. 9, pp. 1983-1999

  14. Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Infectious Diseases and Therapy, Vol. 13, Núm. 11, pp. 2395-2413

2023

  1. Active medical recommendation is the best tool for increasing influenza vaccine coverage in healthy adult workers

    Vacunas, Vol. 24, Núm. 2, pp. 88-94

  2. Adjuvants for COVID-19 Vaccines

    Vaccines, Vol. 11, Núm. 5

  3. An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

    Frontiers in Immunology, Vol. 14

  4. Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

    Frontiers in Immunology, Vol. 14

  5. Group 1 and group 2 hemagglutinin stalk antibody response according to age

    Frontiers in Immunology, Vol. 14

  6. Impact of COVID-19 on Adherence to Treatment in Patients with HIV

    Healthcare (Switzerland), Vol. 11, Núm. 9